Dr. Rham Zaki Ahmed Mohamed
Consultant Oncologist
Medical Oncology
PhD (Medical Oncology), MS (Internal Medicine), MBBCh (Surgery, Medicine), ESMO (European Society for Medical Oncology) Member
About Dr. Rham Zaki Ahmed Mohamed
Dr. Rham Zaki Ahmed Mohamed is a Consultant Oncologist with extensive experience in medical oncology, academic teaching, and cancer research. She has served as a lecturer and assistant lecturer at leading medical institutions in Egypt, while also caring for patients across university and private hospitals.
Her clinical interests include the early detection and treatment of breast, gynaecological, gastrointestinal, and urogenital cancers. Alongside her patient care, she has contributed to several oncology research publications, reflecting her commitment to advancing cancer diagnosis and treatment. Her academic background and clinical expertise distinguish her as the best oncology consultant in Sharjah for comprehensive medical oncology care.
Educational Qualifications
- MBBCh (Surgery, Medicine)
- MS (Internal Medicine)
- PhD (Medical Oncology)
- Member, European Society for Medical Oncology (ESMO)
Special Interests
- Early cancer screening programs
- Diagnosis and treatment of breast cancer
- Diagnosis and treatment of gynaecological cancers
- Diagnosis and treatment of gastrointestinal (GIT) cancers
- Diagnosis and treatment of urogenital cancers
Research / Publications
- Prognostic & Clinicopathological Value of the Expression of FOXC2 & YKL-40 in Carcinoma of the Breast: An Immunohistochemical Study.
- Expression of Silent Information Regulator-1 (SIRT1), CD163 & Tryptase: Implications for Immune Dysregulation, Prognosis and Therapeutic Targeting in Classical Hodgkin Lymphoma.
- The Diagnostic Value of Arginase-1, FTCD & MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver. *Journal of Gastrointestinal Cancer.*
- Co-expression of Epithelial Mesenchymal Transition Markers NEDD9 & Twist in Carcinoma of the Uterine Cervix and Their Clinical Significance. *Journal of Edorium Pathology.*
- Combined EZH2 & p-STAT3 Protein Expression in Renal Cell Carcinoma and Their Significances. *Journal of Edorium Pathology.*
FAQs
Dr. Rham specializes in the diagnosis and treatment of breast, gynaecological, gastrointestinal, and urogenital cancers.
Yes. Early cancer screening programs are among her key clinical interests.
Yes. She has authored and published research on breast cancer, hepatocellular carcinoma, Hodgkin lymphoma, cervical cancer, and renal cell carcinoma.
Yes. She served as a Lecturer in Medical Oncology at Zagazig University Faculty of Medicine and previously worked as an Assistant Lecturer at the National Cancer Institute, Cairo University, and Zagazig University.
Dr. Rham speaks English and Arabic.